Showing 2 of 2 recruiting trials for “OBSOLETE: Lymphoproliferative syndrome”
Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients
👨⚕️ V. Koneti Rao, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 3 sites📅 Started Mar 2025View details ↗
RecruitingNCT06781437 ↗
Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)
👨⚕️ Pier Luigi Zinzani, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Feb 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →